Nasdaq · CIK 0001314102
EYPT EyePoint, Inc.
Insider trading from SEC Form 4. Last filing Mar 24, 2026. Close $3.40 on Oct 9, 2026, +8% from the 52-week low and -82% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
EYPTOct 9, 2026 · close 3.40
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at EyePoint, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Jay S. Duker President and CEO buy | $20k 1,500 shares | +2% | +226% from low-29% from high | |
| 6Weak | Ramiro Ribeiro Chief Medical Officer sell | $44k 2,438 shares | -100% | +336% from low-5% from high | |
| 6Weak | Ramiro Ribeiro Chief Medical Officer sell | $37k 2,437 shares | -100% | +261% from low-21% from high | |
| 21Weak | Ramiro Ribeiro Chief Medical Officer sell | $727k 42,544 shares | -100% | +322% from low-8% from high | |
| 40Moderate | Cormorant Asset Management, LP other sell | $942k 60,000 shares | -1% | - | |
| 14Weak | Nancy Lurker director sell | $140k 9,300 shares | -4% | - | |
| 3Weak | Nancy Lurker director sell | $10k 700 shares | -0% | - | |
| 20Weak | Ramiro Ribeiro Chief Medical Officer sell | $32k 2,722 shares | -100% | - | |
| 33Weak | Karen L. Zaderej director buy | $59k 10,000 shares | +38% | - | |
| 32Weak | Karen L. Zaderej director buy | $54k 10,000 shares | +61% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 23, 2024 | ANTHONY P. ADAMIS Director | 67,100 0.13% of outstanding | $673k | Oct 23, 2024 | none |
| Oct 15, 2024 | David R. Guyer Former Director | 36,975 0.07% of outstanding | $330k | Oct 14, 2024 | none |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Common Stock | -76,766 | $13.11 | $1.0M | 986 | Mar 24, 2026 |
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Common Stockindirect: By Family Trust | +76,766 | $13.11 | $1.0M | 177,431 | Mar 24, 2026 |
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Stock Option (Right to Buy)derivative | -52,500 | $8.75 | $459k | 7,800 | Mar 24, 2026 |
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Stock Option (Right to Buy)derivativeindirect: By Family Trust | +52,500 | $8.75 | $459k | 52,500 | Mar 24, 2026 |
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Stock Option (Right to Buy)derivative | -97,500 | $9.57 | $933k | 82,500 | Mar 24, 2026 |
| Mar 23, 2026 | Jay S. Duker President and CEO | JOther Stock Option (Right to Buy)derivativeindirect: By Family Trust | +97,500 | $9.57 | $933k | 97,500 | Mar 24, 2026 |
| Mar 16, 2026 | Jay S. Duker President and CEO | POpen-market purchase Common Stockindirect: By Family Trust | +1,500 | $13.15 | $20k | 100,665 | Mar 16, 2026 |
| Mar 2, 2026 | George Elston Chief Financial Officer | GGift Common Stock | -5,000 | $0.00 | $0 | 87,818 | Mar 6, 2026 |
| Mar 2, 2026 | George Elston Chief Financial Officer | GGift Common Stockindirect: By Family Trust | +5,000 | $0.00 | $0 | 30,000 | Mar 6, 2026 |
| Mar 4, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Common Stock10b5-1 | +2,438 | $8.26 | $20k | 2,438 | Mar 5, 2026 |
| Mar 4, 2026 | Ramiro Ribeiro Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -2,438 | $17.87 | $44k | 0 | Mar 5, 2026 |
| Mar 4, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,438 | $0.00 | $0 | 82,875 | Mar 5, 2026 |
| Feb 17, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Common Stock10b5-1 | +2,437 | $8.26 | $20k | 2,437 | Feb 18, 2026 |
| Feb 17, 2026 | Ramiro Ribeiro Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -2,437 | $15.00 | $37k | 0 | Feb 18, 2026 |
| Feb 17, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,437 | $0.00 | $0 | 85,313 | Feb 18, 2026 |
| Jan 5, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Common Stock10b5-1 | +29,250 | $8.26 | $242k | 42,544 | Jan 7, 2026 |
| Jan 6, 2026 | Jay S. Duker President and CEO | MOption exercise Common Stock | +20,793 | $0.00 | $0 | 87,806 | Jan 7, 2026 |
| Jan 6, 2026 | Nancy Lurker director | MOption exercise Common Stock | +75,133 | $0.00 | $0 | 294,346 | Jan 7, 2026 |
| Jan 6, 2026 | George Elston Chief Financial Officer | MOption exercise Common Stock | +15,285 | $0.00 | $0 | 96,339 | Jan 7, 2026 |
| Jan 5, 2026 | Ramiro Ribeiro Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -42,544 | $17.10 | $727k | 0 | Jan 7, 2026 |
| Jan 6, 2026 | George Elston Chief Financial Officer | FTax withholding Common Stock | -4,487 | $16.86 | $76k | 91,852 | Jan 7, 2026 |
| Jan 6, 2026 | Jay S. Duker President and CEO | FTax withholding Common Stock | -10,054 | $16.86 | $170k | 77,752 | Jan 7, 2026 |
| Jan 5, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -29,250 | $0.00 | $0 | 87,750 | Jan 7, 2026 |
| Jan 6, 2026 | Nancy Lurker director | MOption exercise Restricted Stock Unitsderivative | -75,133 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Jan 6, 2026 | Jay S. Duker President and CEO | MOption exercise Restricted Stock Unitsderivative | -20,793 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Jan 6, 2026 | George Elston Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -15,285 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Jan 3, 2026 | Jay S. Duker President and CEO | MOption exercise Common Stock | +65,000 | $0.00 | $0 | 74,965 | Jan 6, 2026 |
| Jan 3, 2026 | George Elston Chief Financial Officer | MOption exercise Common Stock | +19,667 | $0.00 | $0 | 76,781 | Jan 6, 2026 |
| Jan 3, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Common Stock | +19,667 | $0.00 | $0 | 19,667 | Jan 6, 2026 |
| Jan 2, 2026 | Reginald J. Sanders director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 2, 2026 | John B. Landis director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 2, 2026 | Goran Ando director | AGrant or award Stock Option (Right to Buy)derivative | +41,500 | $0.00 | $0 | 41,500 | Jan 6, 2026 |
| Jan 2, 2026 | Wendy F Dicicco director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 2, 2026 | Stuart Duty director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 2, 2026 | Fred Hassan director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 2, 2026 | Karen L. Zaderej director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 5, 2026 | Nancy Lurker director | MOption exercise Common Stock | +12,666 | $0.00 | $0 | 219,213 | Jan 6, 2026 |
| Jan 3, 2026 | Jay S. Duker President and CEO | FTax withholding Common Stock | -23,447 | $17.48 | $410k | 51,518 | Jan 6, 2026 |
| Jan 3, 2026 | George Elston Chief Financial Officer | FTax withholding Common Stock | -6,324 | $17.48 | $111k | 70,457 | Jan 6, 2026 |
| Jan 3, 2026 | Ramiro Ribeiro Chief Medical Officer | FTax withholding Common Stock | -6,373 | $17.48 | $111k | 13,294 | Jan 6, 2026 |
| Jan 5, 2026 | Jay S. Duker President and CEO | MOption exercise Common Stock | +30,000 | $0.00 | $0 | 81,518 | Jan 6, 2026 |
| Jan 2, 2026 | Nancy Lurker director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 5, 2026 | George Elston Chief Financial Officer | MOption exercise Common Stock | +15,000 | $0.00 | $0 | 85,457 | Jan 6, 2026 |
| Jan 2, 2026 | Ramiro Ribeiro Chief Medical Officer | AGrant or award Restricted Stock Unitsderivative | +85,700 | $0.00 | $0 | 85,700 | Jan 6, 2026 |
| Jan 5, 2026 | Jay S. Duker President and CEO | FTax withholding Common Stock | -14,505 | $17.43 | $253k | 67,013 | Jan 6, 2026 |
| Jan 5, 2026 | George Elston Chief Financial Officer | FTax withholding Common Stock | -4,403 | $17.43 | $77k | 81,054 | Jan 6, 2026 |
| Jan 2, 2026 | Ramiro Ribeiro Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +171,400 | $0.00 | $0 | 171,400 | Jan 6, 2026 |
| Jan 5, 2026 | Nancy Lurker director | MOption exercise Restricted Stock Unitsderivative | -12,666 | $0.00 | $0 | 12,667 | Jan 6, 2026 |
| Jan 3, 2026 | Ramiro Ribeiro Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -19,667 | $0.00 | $0 | 39,333 | Jan 6, 2026 |
| Jan 2, 2026 | Jay S. Duker President and CEO | AGrant or award Restricted Stock Unitsderivative | +165,000 | $0.00 | $0 | 165,000 | Jan 6, 2026 |
| Jan 2, 2026 | George Elston Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +63,000 | $0.00 | $0 | 63,000 | Jan 6, 2026 |
| Jan 2, 2026 | Jay S. Duker President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +331,000 | $0.00 | $0 | 331,000 | Jan 6, 2026 |
| Jan 2, 2026 | George Elston Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +126,000 | $0.00 | $0 | 126,000 | Jan 6, 2026 |
| Jan 3, 2026 | Jay S. Duker President and CEO | MOption exercise Restricted Stock Unitsderivative | -65,000 | $0.00 | $0 | 130,000 | Jan 6, 2026 |
| Jan 3, 2026 | George Elston Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -19,667 | $0.00 | $0 | 39,333 | Jan 6, 2026 |
| Jan 5, 2026 | Jay S. Duker President and CEO | MOption exercise Restricted Stock Unitsderivative | -30,000 | $0.00 | $0 | 30,000 | Jan 6, 2026 |
| Jan 5, 2026 | George Elston Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -15,000 | $0.00 | $0 | 15,000 | Jan 6, 2026 |
| Dec 19, 2025 | George Elston Chief Financial Officer | GGift Common Stock | -5,000 | $0.00 | $0 | 57,114 | Dec 23, 2025 |
| Dec 19, 2025 | George Elston Chief Financial Officer | GGift Common Stockindirect: By Family Trust | +5,000 | $0.00 | $0 | 25,000 | Dec 23, 2025 |
| Dec 4, 2025 | Cormorant Asset Management, LP other | SOpen-market sale Common Stockindirect: See Footnotes | -60,000 | $15.70 | $942k | 8,265,000 | Dec 8, 2025 |
| Dec 4, 2025 | Nancy Lurker director | SOpen-market sale Common Stock10b5-1 | -9,300 | $15.11 | $140k | 206,547 | Dec 5, 2025 |
| Nov 26, 2025 | Nancy Lurker director | SOpen-market sale Common Stock10b5-1 | -200 | $14.95 | $2,990 | 216,347 | Dec 1, 2025 |
| Nov 28, 2025 | Nancy Lurker director | SOpen-market sale Common Stock10b5-1 | -500 | $14.95 | $7,475 | 215,847 | Dec 1, 2025 |
| Nov 11, 2025 | Ramiro Ribeiro Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -2,722 | $11.61 | $32k | 0 | Nov 12, 2025 |
| Sep 19, 2025 | George Elston Chief Financial Officer | GGift Common Stock | -20,000 | $0.00 | $0 | 62,114 | Sep 22, 2025 |
| Sep 19, 2025 | George Elston Chief Financial Officer | GGift Common Stockindirect: By Family Trust | +20,000 | $0.00 | $0 | 20,000 | Sep 22, 2025 |
| Jul 11, 2025 | Karen L. Zaderej director | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 38,500 | Jul 11, 2025 |
| Jul 10, 2025 | Jay S. Duker President and CEO | MOption exercise Common Stock | +16,667 | $0.00 | $0 | 17,653 | Jul 11, 2025 |
| Jul 10, 2025 | Nancy Lurker director | MOption exercise Common Stock | +11,111 | $0.00 | $0 | 216,547 | Jul 11, 2025 |
| Jul 11, 2025 | Karen L. Zaderej director | MOption exercise Restricted Stock Unitsderivative | -2,000 | $0.00 | $0 | 0 | Jul 11, 2025 |
| Jul 10, 2025 | Jay S. Duker President and CEO | FTax withholding Common Stock | -7,688 | $11.06 | $85k | 9,965 | Jul 11, 2025 |
| Jul 10, 2025 | Nancy Lurker director | MOption exercise Restricted Stock Unitsderivative | -11,111 | $0.00 | $0 | 11,112 | Jul 11, 2025 |
| Jul 10, 2025 | Jay S. Duker President and CEO | MOption exercise Restricted Stock Unitsderivative | -16,667 | $0.00 | $0 | 16,667 | Jul 11, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivative | -31,165 | $0.00 | $0 | 0 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +31,165 | $0.00 | $0 | 213,700 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 40,000 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +55,000 | $0.00 | $0 | 200,000 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivative | -103,308 | $0.00 | $0 | 178,442 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +103,308 | $0.00 | $0 | 272,358 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivative | -15,278 | $0.00 | $0 | 34,722 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +15,278 | $0.00 | $0 | 31,944 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivative | -27,270 | $0.00 | $0 | 49,730 | Jul 2, 2025 |
| Jul 2, 2025 | Nancy Lurker director | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +27,270 | $0.00 | $0 | 27,270 | Jul 2, 2025 |
| Jun 23, 2025 | Jay S. Duker President and CEO | JOther Common Stock | -56,665 | $8.21 | $465k | 986 | Jun 25, 2025 |
| May 25, 2025 | George Elston Chief Financial Officer | MOption exercise Common Stock | +7,500 | $0.00 | $0 | 83,050 | May 27, 2025 |
| May 25, 2025 | George Elston Chief Financial Officer | FTax withholding Common Stock | -2,202 | $5.68 | $13k | 80,848 | May 27, 2025 |
| May 25, 2025 | George Elston Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -7,500 | $0.00 | $0 | 7,500 | May 27, 2025 |
| May 16, 2025 | Karen L. Zaderej director | POpen-market purchase Common Stock | +5,000 | $5.81 | $29k | 31,500 | May 19, 2025 |
| May 19, 2025 | Karen L. Zaderej director | POpen-market purchase Common Stock | +5,000 | $5.99 | $30k | 36,500 | May 19, 2025 |
| May 14, 2025 | Karen L. Zaderej director | POpen-market purchase Common Stock | +5,000 | $5.42 | $27k | 21,500 | May 15, 2025 |
| May 15, 2025 | Karen L. Zaderej director | POpen-market purchase Common Stock | +5,000 | $5.47 | $27k | 26,500 | May 15, 2025 |
| Mar 19, 2025 | Jay S. Duker President and CEO | JOther Common Stock | -20,000 | $6.16 | $123k | 57,651 | Mar 20, 2025 |
| Feb 9, 2025 | Jay S. Duker President and CEO | MOption exercise Common Stock | +7,000 | $0.00 | $0 | 79,706 | Feb 11, 2025 |
| Feb 9, 2025 | George Elston Chief Financial Officer | MOption exercise Common Stock | +5,834 | $0.00 | $0 | 75,550 | Feb 11, 2025 |
| Feb 9, 2025 | Nancy Lurker director | MOption exercise Common Stock | +20,000 | $0.00 | $0 | 205,436 | Feb 11, 2025 |
| Feb 9, 2025 | Jay S. Duker President and CEO | FTax withholding Common Stock | -2,055 | $6.50 | $13k | 77,651 | Feb 11, 2025 |
| Feb 9, 2025 | George Elston Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -5,834 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 9, 2025 | Nancy Lurker director | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 9, 2025 | Jay S. Duker President and CEO | MOption exercise Restricted Stock Unitsderivative | -7,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Jan 8, 2025 | Reginald J. Sanders director | AGrant or award Stock Options (Right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Jan 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Goran Andodirector
- Cormorant Asset Management, LPowner, other
- Wendy F Diciccodirector
- Jay S. DukerPresident and CEO
- Stuart Dutydirector
- George ElstonChief Financial Officer
- Fred Hassandirector
- John B. Landisdirector
- Nancy Lurkerdirector
- Ramiro RibeiroChief Medical Officer
- Reginald J. Sandersdirector
- Karen L. Zaderejdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.